Grupa Farmacol is one of the largest Polish companies in the manufacturing and pharmaceutical industries. Since 1990, they have been supplying medicines to pharmacies, hospitals, and pharmaceutical wholesalers, with one in five drugs sold in Poland originating from their warehouses. They consistently provide high-quality services and monthly supply nearly 10,000 pharmacies across the country. Their mission is to ensure the availability of medicines for pharmacies and patients nationwide. With a workforce of over 4,000 individuals, the company operates across various market segments, leveraging the knowledge, skills, and experience of its employees. As a content writer and startup/investor analyst, it's notable that Grupa Farmacol has established a strong presence in the pharmaceutical sector and has contributed significantly to the healthcare industry in Poland. Although specific details about their latest investment and investors are not available currently, their extensive experience, widespread operations, and market impact make them a noteworthy company for potential investors and venture capitalists to consider.
There is no investment information
No recent news or press coverage available for Grupa Farmacol.